DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @AmericanBanking | 10 |
| @ThisLincolnian | 8 |
| @bibeypost_stock | 8 |
| @whatsonthorold2 | 8 |
| @BlogYomi | 7 |
Recent Tweets for DRNA
 |
@OlympiaReport Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Quarterly Sales of $10.59 Million https://t.co/HVS4xqUJ1J March 21st 2019, 7:03pm |
 |
@dispatchtribune Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Quarterly Sales of $10.59 Million https://t.co/q3JinVup9T March 21st 2019, 7:03pm |
 |
@Stock_News_Now $DRNA: New SEC Filing for DRNA: Form CT ORDER (No. 9999999997-19-001690): https://t.co/jDd2s35CMp March 21st 2019, 11:03am |
 |
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form CT ORDER https://t.co/DdQWCtDDre March 21st 2019, 10:03am |
 |
@BlogYomi Contrasting of Bellerophon Therapeutics Inc. $DRNA https://t.co/96AGWUx2Ph March 20th 2019, 7:03pm |
 |
@brockthornhill RT @mikegoodma: $DRNA putting on a little bit of weight every day. Dosing of the first patient with HBV in the 2nd portion of the study sho… March 20th 2019, 5:03pm |
 |
@mikegoodma $DRNA putting on a little bit of weight every day. Dosing of the first patient with HBV in the 2nd portion of the s… https://t.co/0LAV7yLh4e March 20th 2019, 5:03pm |
 |
@thefinreviewer Perigon Wealth Management Has Boosted Its Mcdonalds $MCD Stake; Dicerna Pharmaceuticals, Inc. $DRNA Had 7 Bulls https://t.co/3mHLtzr1qS March 20th 2019, 1:03pm |
 |
@mmahotstuff1 What's Propelling Dicerna Pharmaceuticals, Inc. $DRNA to Increase So Much? https://t.co/LJgOOnCLpi March 20th 2019, 1:03pm |
 |
@whatsonthorold2 Dicerna Pharmaceuticals, Inc. $DRNA's Stock Is Buy After Today's Huge Increase https://t.co/0orb7k06cW March 20th 2019, 1:03pm |
 |
@bibeypost_stock Dicerna Pharmaceuticals, Inc. $DRNA Just Recorded A Sigfniciant Increase https://t.co/dZEx15wItR March 20th 2019, 1:03pm |
|
@OlympiaReport Dicerna Pharmaceuticals Inc $DRNA Given Consensus Rating of “Buy” by Brokerages https://t.co/8sTdJIBKzF March 20th 2019, 1:03pm |
|
@dispatchtribune Dicerna Pharmaceuticals Inc $DRNA Receives $21.78 Average PT from Analysts https://t.co/pHGYm84Hnd March 20th 2019, 1:03pm |
 |
@NewsToDesk $DRNA: Will Dicerna Pharmaceuticals, Inc.’s (NASDAQ:DRNA) Earnings …: https://t.co/2o6rFLdEmM March 20th 2019, 12:03pm |
 |
@UlmHi Reviewing PhaseBio Pharmaceuticals Inc. $DRNA's results https://t.co/DAlHtKNsRg March 20th 2019, 1:03am |
|
@UlmHi Neuralstem Inc. $DRNA Comparing side by side https://t.co/K4wEh2Np81 March 19th 2019, 11:03pm |
|
@UlmHi Immune Design Corp. $DRNA https://t.co/l2aJjw20PI March 19th 2019, 11:03pm |
 |
@ConsumerFeed Dicerna Pharmaceuticals Inc $DRNA Expected to Post Quarterly Sales of $10.59 Million https://t.co/dFwCKw4682 March 19th 2019, 1:03pm |
 |
@WeekHerald Dicerna Pharmaceuticals Inc $DRNA Expected to Post Earnings of -$0.22 Per Share https://t.co/9pe3Vab6L6 March 19th 2019, 1:03pm |
|
@OlympiaReport Dicerna Pharmaceuticals Inc $DRNA Expected to Post Earnings of -$0.22 Per Share https://t.co/wEbeJziIlt March 19th 2019, 1:03pm |
 |
@bulletin_en As Dicerna Pharmaceuticals INC $DRNA Shares Declined, Ra Capital Management LLC Decreased by $14.77 Million Its Sta… https://t.co/oozh37Qi10 March 19th 2019, 7:03am |
|
@BlogYomi Ghost Tree Capital Has Boosted Dicerna Pharmaceuticals $DRNA Stake by $1.50 Million; Market Value Declined; Zillow… https://t.co/RyKhyZGhg0 March 18th 2019, 4:03pm |
 |
@stocknewstimes Zacks Investment Research Lowers Dicerna Pharmaceuticals $DRNA to Hold https://t.co/zPkGmc0bXX March 18th 2019, 10:03am |
 |
@ChickenhawkBob Sold $DRNA + $161 + 6.5% then Bought Back - Profits in the Pocket! https://t.co/AzlOh9VEHi March 18th 2019, 10:03am |
|
@BlogYomi SolarWinds $SWI Got Lower Goldman Sachs Rating; Last Week Dicerna Pharmaceuticals, Inc. $DRNA Coverage https://t.co/Jv3TfC8vsS March 18th 2019, 8:03am |
 |
@TranscriptDaily Dicerna Pharmaceuticals Inc $DRNA Given Average Rating of “Buy” by Brokerages https://t.co/ZZ36LWq1f3 March 18th 2019, 7:03am |
 |
@dakotafinancial Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Hold https://t.co/A0cPXKD5Ex March 17th 2019, 12:03pm |
|
@ConsumerFeed Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.22 Per Share https://t.co/tHXHoOHEma March 17th 2019, 11:03am |
 |
@WatchlistN $10.59 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/pOVE3JjIZH March 17th 2019, 11:03am |
|
@bibeypost_stock Ra Capital Management LLC Has Lowered Dicerna Pharmaceuticals INC $DRNA Holding by $14.77 Million https://t.co/iQU7aMWZvL March 17th 2019, 9:03am |
 |
@reurope_stock Ra Capital Management LLC Has Trimmed Dicerna Pharmaceuticals INC $DRNA Stake by $14.77 Million; Share Value Declin… https://t.co/mTrHoWtCTL March 17th 2019, 9:03am |
 |
@1MinuteStock Wondering about #sentiment indicator for $DRNA? The Short Ratio is 15.75% https://t.co/cK96TdziHl March 17th 2019, 9:03am |
|
@dispatchtribune Dicerna Pharmaceuticals $DRNA Price Target Increased to $26.00 by Analysts at SunTrust Banks https://t.co/s92PlVi27q March 17th 2019, 8:03am |
 |
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Price Target Increased to $26.00 by Analysts at SunTrust Banks https://t.co/CC8qMrdqwS March 17th 2019, 8:03am |
 |
@bbnsnews Dicerna Pharmaceuticals $DRNA Given New $24.00 Price Target at B. Riley https://t.co/ifqCnGAhBC March 17th 2019, 5:03am |
|
@ThisLincolnian Q1 2019 Earnings Forecast for Dicerna Pharmaceuticals Inc Issued By Svb Leerink $DRNA https://t.co/Livu79BXhz March 17th 2019, 1:03am |
|
@WeekHerald Dicerna Pharmaceuticals Inc $DRNA to Post Q1 2019 Earnings of -$0.43 Per Share, SunTrust Banks Forecasts https://t.co/gGIx8GYxoV March 17th 2019, 1:03am |
|
@OlympiaReport Dicerna Pharmaceuticals Inc $DRNA to Post Q1 2019 Earnings of -$0.43 Per Share, SunTrust Banks Forecasts https://t.co/voujYkwzps March 17th 2019, 1:03am |
|
@BlogYomi Reviewing Homology Medicines Inc. $DRNA's results https://t.co/yVZxV21tnH March 16th 2019, 8:03pm |
|
@WeekHerald Dicerna Pharmaceuticals $DRNA PT Raised to $26.00 https://t.co/uiPV3Xe4nd March 16th 2019, 6:03pm |
 |
@registrarjourn Dicerna Pharmaceuticals $DRNA Price Target Raised to $24.00 https://t.co/zJXN8BpOnn March 16th 2019, 6:03pm |
 |
@EnterpriseLeade Dicerna Pharmaceuticals $DRNA Price Target Raised to $24.00 https://t.co/SnrzvpD8EO March 16th 2019, 6:03pm |
|
@ThisLincolnian Zacks Investment Research Upgrades Dicerna Pharmaceuticals $DRNA to “Buy” https://t.co/S5fDSCy1h0 March 16th 2019, 6:03pm |
|
@OlympiaReport SunTrust Banks Boosts Dicerna Pharmaceuticals $DRNA Price Target to $26.00 https://t.co/TJaMTtLWsH March 16th 2019, 6:03pm |
 |
@TickerReport Dicerna Pharmaceuticals Inc $DRNA Receives $21.78 Average PT from Brokerages https://t.co/SPruhzMuAC March 16th 2019, 6:03pm |
|
@bibeypost_stock It's been a crucial week for Dicerna Pharmaceuticals, Inc. $DRNA; here's what analysts have to say. https://t.co/ATNvcfXMF6 March 16th 2019, 8:03am |
|
@TranscriptDaily Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/b6x832ha69 March 16th 2019, 4:03am |
|
@registrarjourn Dicerna Pharmaceuticals $DRNA Downgraded to “Hold” at BidaskClub https://t.co/aSZnzIpSgL March 16th 2019, 3:03am |
|
@EnterpriseLeade Dicerna Pharmaceuticals $DRNA Downgraded to “Hold” at BidaskClub https://t.co/Yxc5AZGz26 March 16th 2019, 3:03am |
|
@registrarjourn Dicerna Pharmaceuticals Inc $DRNA to Post Q1 2019 Earnings of -$0.43 Per Share, SunTrust Banks Forecasts https://t.co/nQAk8JwpYV March 16th 2019, 2:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.